This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
R18_SYMPTOMS_SIGNS_ABNORMAL_CLINI_LABOR_FINDI_NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
R00-R99
Hospital discharge: ICD-9
7[8-9]
Hospital discharge: ICD-8
7[8-9]
Cause of death: ICD-10
R00-R99
Cause of death: ICD-9
7[8-9]
Cause of death: ICD-8
7[8-9]
2 out of 7 registries used, show all original rules.
297912
Check minimum number of events None
297912
Include endpoints None
297912
Remove individuals based on genotype QC
286599
R18_SYMPTOMS_SIGNS_ABNORMAL_CLINI_LABOR_FINDI_NOT_ELSEW_CLASSIFIED
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
1
First used in FinnGen datafreeze
DF4
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
based on the number of shared cases.
Broader endpoints:
None
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 286599 | 163050 | 123549 |
| Unadjusted prevalence (%) | 69.57 | 70.82 | 67.98 |
| Mean age at first event (years) | 46.54 | 42.59 | 51.75 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: R18_SYMPTOMS_SIGNS_ABNORMAL_CLINI_LABOR_FINDI_NOT_ELSEW_CLASSIFIED – Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
↥Endpoint not on priority list, no data to show.